Hangzhou Institute of Innovative Medicine, Institute of Pharmacology and Toxicology, Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang 310058, China.
Center for the Study of Itch and Sensory Disorders, Washington University School of Medicine, St Louis, MO 63110.
Proc Natl Acad Sci U S A. 2023 Feb 7;120(6):e2216230120. doi: 10.1073/pnas.2216230120. Epub 2023 Feb 1.
Gastrin releasing peptide receptor (GRPR), a member of the bombesin (BBN) G protein-coupled receptors, is aberrantly overexpressed in several malignant tumors, including those of the breast, prostate, pancreas, lung, and central nervous system. Additionally, it also mediates non-histaminergic itch and pathological itch conditions in mice. Thus, GRPR could be an attractive target for cancer and itch therapy. Here, we report the inactive state crystal structure of human GRPR in complex with the non-peptide antagonist PD176252, as well as two active state cryo-electron microscopy (cryo-EM) structures of GRPR bound to the endogenous peptide agonist gastrin-releasing peptide and the synthetic BBN analog [D-Phe, β-Ala, Phe, Nle] Bn (6-14), in complex with G heterotrimers. These structures revealed the molecular mechanisms for the ligand binding, receptor activation, and G proteins signaling of GRPR, which are expected to accelerate the structure-based design of GRPR antagonists and agonists for the treatments of cancer and pruritus.
胃泌素释放肽受体(GRPR)是脑肠肽家族成员之一,属于 G 蛋白偶联受体,在多种恶性肿瘤中异常过表达,包括乳腺癌、前列腺癌、胰腺癌、肺癌和中枢神经系统肿瘤等。此外,它还介导了小鼠的非组胺性瘙痒和病理性瘙痒。因此,GRPR 可能成为癌症和瘙痒治疗的一个有吸引力的靶点。在这里,我们报道了人源 GRPR 与非肽类拮抗剂 PD176252 复合物的无活性状态晶体结构,以及与内源性肽激动剂胃泌素释放肽和合成的 BBN 类似物 [D-Phe,β-Ala,Phe,Nle] Bn(6-14)结合的 GRPR 的两种活性状态冷冻电镜(cryo-EM)结构,与 G 三聚体复合物。这些结构揭示了 GRPR 的配体结合、受体激活和 G 蛋白信号转导的分子机制,有望加速基于结构的 GRPR 拮抗剂和激动剂的设计,用于癌症和瘙痒的治疗。